News About: Pharm. Affairs
Medical associations lead public opinions about antidepressant health insurance
Associations specializing in nervous system and psychiatry will prepare for a place to share public opinions related to the top 4 nervous system diseases – epilepsy, dementia, Parkinson’s disease and stroke – and trea...
What is meaning of insurance benefit extension to adults for ADHD treatments?
Attention Deficit Hyperactivity Disorders(ADHD) is not a disorder limited to children. According to doctors, there are lots of adult ADHD patients.
However, adult ADHD patients usually take it not seriously enough ...
Government plans to cut insurance registration period to less than 240 days
The new antibodies’ insurance registration period is expected to be drastically decreased.
The Ministry of Health and Welfare(Minister Jin-yup Jung, MOHW) and the Health Insurance Review & Assessment Service(Chief D...
Availability of early lunch for ‘Mabthera’ biosimilar in Korea
‘Truxima,’ a biosimilar antibody developed by Celltrion from ‘Mabthera Inj(foreign name: Rituxan),’ got the green light for its early domestic launch as winning a series of patent suits.
Mabthera is a treatment sold ...
Celltrion’s Remsima wins U.S. original drug substance patent conflict
On a summary judgement filed by Celltrion over the Remicade’s substance patent(U.S. Patent No. 6,284,471, hereinafter referring to ‘471 substance patent’), the United States District Court for the District of Massachu...
Reverse strategy to export introduced drug through sales license
The key is just out-of-the-box thinking. While the Pharmerging(pharmacy + emerging) market is considered as a breakthrough to enter the global market, Boryung Pharm’s differentiated export strategy brought an implicat...
AZ to defend patents through alternation of salt, but Tribunal said ‘nothing for patent’
AstraZeneca applied for an appeal to the nullification of patents related to substance and more in Korea, it was not able to get the rights back. It is analyzed the AstraZeneca’s strategy to take a favorable position ...
MSD plans to occupy cervical cancer vaccine market using ‘Gardasil9’Since cervical cancer vaccines will be included in the National Immunization Program(NIP) from this June, the private cervical cancer vaccine market is also expected to get enla...
|
Hospital pharmacists working on surveying multinational pharmaceuticals’ out-of-stock status
In order to solve multinational pharmaceutical companies’ frequent pharmaceutical out-of-stock status, pharmacists of each hospital started to investigate actual conditions in the field.
They plan to seek for counter...
Pfizer announces approval of Ibrance is getting closerA targeted therapy for HER2 negative breast cancer is going to be introduced in Korea.
According to the industry concerned on the 16th, a Pfizer Pharmaceuticals Korea’s new br...
|
